AR026066A1 - Particulas virales con epitopos internos exogenos. - Google Patents
Particulas virales con epitopos internos exogenos.Info
- Publication number
- AR026066A1 AR026066A1 ARP000105455A ARP000105455A AR026066A1 AR 026066 A1 AR026066 A1 AR 026066A1 AR P000105455 A ARP000105455 A AR P000105455A AR P000105455 A ARP000105455 A AR P000105455A AR 026066 A1 AR026066 A1 AR 026066A1
- Authority
- AR
- Argentina
- Prior art keywords
- expression
- viruses
- viral particles
- epithopes
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9924352.9A GB9924352D0 (en) | 1999-10-14 | 1999-10-14 | Methods,compositions and applications relating to the generation of novel plant viral particles |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026066A1 true AR026066A1 (es) | 2002-12-26 |
Family
ID=10862753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105455A AR026066A1 (es) | 1999-10-14 | 2000-10-17 | Particulas virales con epitopos internos exogenos. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1235910A1 (zh) |
JP (1) | JP2003534771A (zh) |
KR (1) | KR100880477B1 (zh) |
CN (2) | CN1471580A (zh) |
AR (1) | AR026066A1 (zh) |
AU (1) | AU785020B2 (zh) |
BR (1) | BR0014861A (zh) |
CA (1) | CA2387626A1 (zh) |
CO (1) | CO5280142A1 (zh) |
CZ (1) | CZ20021303A3 (zh) |
GB (1) | GB9924352D0 (zh) |
IL (1) | IL149077A0 (zh) |
MX (1) | MXPA02003789A (zh) |
PL (1) | PL354933A1 (zh) |
WO (1) | WO2001027282A1 (zh) |
ZA (1) | ZA200202815B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003000855A2 (en) * | 2001-06-21 | 2003-01-03 | Uab Research Foundation | Chimeric capsid proteins and uses thereof |
KR20050044886A (ko) | 2002-07-05 | 2005-05-13 | 데니스 르클레르 | 면역보조 바이러스 입자 |
US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
CA2583113C (en) | 2004-10-05 | 2015-11-10 | Diversa Corporation | Compositions comprising an antigen and a promiscuous t-cell epitope |
US20070041999A1 (en) * | 2005-06-01 | 2007-02-22 | Lada Rasochova | Production of multivalent virus like particles |
AU2006270065A1 (en) * | 2005-07-19 | 2007-01-25 | Dow Global Technologies Inc. | Recombinant flu vaccines |
CA2685308A1 (en) * | 2007-04-27 | 2009-01-29 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
WO2013003353A2 (en) * | 2011-06-30 | 2013-01-03 | Stc.Unm | Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9108386D0 (en) * | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
GB9712282D0 (en) * | 1997-06-12 | 1997-08-13 | Innes John Centre Innov Ltd | Epitope presentation system |
-
1999
- 1999-10-14 GB GBGB9924352.9A patent/GB9924352D0/en not_active Ceased
-
2000
- 2000-10-13 BR BR0014861-0A patent/BR0014861A/pt not_active Application Discontinuation
- 2000-10-13 CA CA002387626A patent/CA2387626A1/en not_active Abandoned
- 2000-10-13 CZ CZ20021303A patent/CZ20021303A3/cs unknown
- 2000-10-13 CN CNA008167532A patent/CN1471580A/zh active Pending
- 2000-10-13 WO PCT/US2000/028430 patent/WO2001027282A1/en active Application Filing
- 2000-10-13 JP JP2001530485A patent/JP2003534771A/ja active Pending
- 2000-10-13 EP EP00972153A patent/EP1235910A1/en not_active Withdrawn
- 2000-10-13 MX MXPA02003789A patent/MXPA02003789A/es unknown
- 2000-10-13 CN CNA2009101426265A patent/CN101591647A/zh active Pending
- 2000-10-13 KR KR1020027004778A patent/KR100880477B1/ko not_active IP Right Cessation
- 2000-10-13 PL PL00354933A patent/PL354933A1/xx unknown
- 2000-10-13 IL IL14907700A patent/IL149077A0/xx unknown
- 2000-10-13 AU AU10852/01A patent/AU785020B2/en not_active Ceased
- 2000-10-17 AR ARP000105455A patent/AR026066A1/es unknown
- 2000-10-17 CO CO00078905A patent/CO5280142A1/es not_active Application Discontinuation
-
2002
- 2002-04-10 ZA ZA200202815A patent/ZA200202815B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA02003789A (es) | 2002-09-30 |
ZA200202815B (en) | 2003-08-27 |
BR0014861A (pt) | 2002-07-16 |
PL354933A1 (en) | 2004-03-22 |
KR100880477B1 (ko) | 2009-01-28 |
CN101591647A (zh) | 2009-12-02 |
EP1235910A1 (en) | 2002-09-04 |
CO5280142A1 (es) | 2003-05-30 |
GB9924352D0 (en) | 1999-12-15 |
WO2001027282A8 (en) | 2001-08-16 |
AU1085201A (en) | 2001-04-23 |
KR20020040868A (ko) | 2002-05-30 |
WO2001027282A1 (en) | 2001-04-19 |
CN1471580A (zh) | 2004-01-28 |
IL149077A0 (en) | 2002-11-10 |
CA2387626A1 (en) | 2001-04-19 |
AU785020B2 (en) | 2006-08-24 |
JP2003534771A (ja) | 2003-11-25 |
CZ20021303A3 (cs) | 2002-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
EA200900784A1 (ru) | Вакцины, включающие антиген из четырех штаммов вируса гриппа | |
CO2018005265A2 (es) | Vacunas de ácido nucleico para el virus varicela-zóster | |
PE20110020A1 (es) | Inmunomodulacion mediante el uso de celulas madres de la placenta | |
PE20220379A1 (es) | Suministro de biomoleculas a pbmc para modificar una respuesta inmune | |
ES2103001T3 (es) | Vacunas. | |
DK1294893T3 (da) | Modifikation af hepatitis B-kerneantigen | |
AR026066A1 (es) | Particulas virales con epitopos internos exogenos. | |
UY30485A1 (es) | Uso antiviral de un tensioactivo cationico | |
ES2263406T1 (es) | Produccion de proteina capsida l1 y particulas tipo virus de papilomavirus humano hbv-11. | |
EA201270191A1 (ru) | Лентивирусные векторы, псевдотипированные гликопротеином оболочки вируса синдбис | |
AR248426A1 (es) | Produccion de particulas incorporadas a un virus vegetal que contiene un peptido antigenico, con el fin de preparar una vacuna de virus animal. | |
AR033574A1 (es) | Una cepa bacteriana del grupo de las bacterias lacticas capaces de reducir la tendencia de un individuo a desarrollar reacciones alergicas, las composiciones alimenticias y farmaceuticas que la contienen y las vacunas que la contienen | |
AR058049A1 (es) | Proteina de la capsida del virus dengue inductora de respuesta protectora y composicion farmaceutica | |
WO2008148104A8 (en) | Novel vlps derived from cells that do not express a viral matrix or core protein | |
AR115069A1 (es) | Virus vacuna quimérico sintético | |
PA8813901A1 (es) | Paramixovirus oncolíticos atenuados que codifican citoquinas de aves | |
WO2007046839A3 (en) | New live virus vaccines | |
AR004464A1 (es) | Un metodo para producir una proteina de capside de papilomavirus | |
WO2011150320A3 (en) | Activators of innate immunity | |
IL265524B2 (en) | complex glycoproteins | |
EP1420819A4 (en) | SECONDARY VACCINE FOR INFECTIOUS PANCREASCRECIS VIRUS | |
BRPI0411099A (pt) | composições imunogênicas que compreendem os vetores de replicon do vìrus da encefalite eqüina venezuelana e antìgenos de proteìnas de paramixovìrus | |
CL2008003821A1 (es) | Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado | |
WO2002038793A3 (en) | Hepatitis c virus constructs characterized by high efficiency replication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |